Trupanion (NASDAQ:TRUP) Sees Strong Trading Volume
Trupanion, Inc. (NASDAQ:TRUP) saw unusually-strong trading volume on Thursday . Approximately 20,205 shares were traded during trading, a decline of 95% from the previous session’s volume of 428,174 shares.The stock last traded at $72.70 and had previously closed at $72.00.
A number of equities research analysts recently issued reports on TRUP shares. Zacks Investment Research downgraded shares of Trupanion from a “hold” rating to a “strong sell” rating in a research note on Tuesday, February 16th. Evercore ISI began coverage on shares of Trupanion in a research note on Monday. They issued an “outperform” rating and a $100.00 target price on the stock. Lake Street Capital increased their target price on shares of Trupanion from $85.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, February 11th. Finally, Canaccord Genuity increased their target price on shares of Trupanion from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, February 11th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $86.57.
The stock’s fifty day moving average price is $88.16 and its 200 day moving average price is $96.90. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.56 and a quick ratio of 1.56. The stock has a market capitalization of $2.93 billion, a P/E ratio of -1,799.55 and a beta of 2.01.
In other Trupanion news, insider Gavin Friedman sold 400 shares of the stock in a transaction dated Thursday, April 1st. The shares were sold at an average price of $77.69, for a total transaction of $31,076.00. Following the transaction, the insider now directly owns 941 shares in the company, valued at approximately $73,106.29. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction dated Wednesday, March 17th. The stock was sold at an average price of $91.92, for a total transaction of $367,680.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 146,062 shares of company stock worth $14,745,514. Company insiders own 13.61% of the company’s stock.
Institutional investors have recently modified their holdings of the business. Archer Investment Corp bought a new position in Trupanion during the 4th quarter worth about $39,000. Berman Capital Advisors LLC bought a new stake in shares of Trupanion in the 4th quarter valued at about $43,000. Vantage Consulting Group Inc bought a new stake in shares of Trupanion in the 4th quarter valued at about $57,000. Strs Ohio bought a new stake in shares of Trupanion in the 3rd quarter valued at about $55,000. Finally, Captrust Financial Advisors bought a new stake in shares of Trupanion in the 3rd quarter valued at about $84,000. Institutional investors own 89.43% of the company’s stock.
Trupanion Company Profile (NASDAQ:TRUP)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc changed its name to Trupanion, Inc in 2013.
Featured Story: Why is the price-sales ratio important?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.